Cinryze: Drug Insights 2018-2022 - ResearchAndMarkets.com

DUBLIN--()--The "Cinryze - Drug Insights, 2018" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive information of the drug, Cinryze. It includes Cinryze's overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Cinryze's patents (US & EU). It also features the historical and forecasted sales of Cinryze till 2022.

The report also throws light on Cinryze's market competition and emerging therapies in the same space as Cinryze. A SWOT analysis of the drug is also featured.

Overview of development activities around Cinryze

  • The segment comprises of detailed description of the product especially highlighting its regulatory milestones, research and development, deals & partnerships, patent and technology details
  • Global Sales Assessment and analysis of market competition
  • Graphical representation of historical and forecasted global sales of Cinryze till 2022 and marked attention on the current market competition and upcoming emerging therapies in the same space

Scope

  • A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Patent information around Cinryze in the United States (US) and Europe (EU) has been highlighted
  • The report contains historical and forecasted sales for Cinryze till 2022
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Cinryze operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the SWOT analysis of Cinryze

Key Topics Covered

  1. Introduction
  2. Cinryze - Overview
  3. Product Description
  4. Dosage and Strengths
  5. Route of Synthesis
  6. Mechanism of Action
  7. Pharmacology
  8. Pharmacodynamics
  9. Pharmacokinetics
  10. Adverse Reactions
  11. Clinical Studies
  12. Adolescent & Adult Study Results
  13. Pediatric Study Results
  14. Other Pipeline Activity
  15. Regulatory Milestones
  16. European Market Approval
  17. United States Approval
  18. Supplemental Biologics License Application (sBLA)
  19. Acquisition
  20. Technology
  21. Designation
  22. Agreement
  23. Technology Transfer
  24. Marketed Details
  25. United States
  26. Europe
  27. Cinryze Sales Assessment
  28. Global
  29. Analyst Insights
  30. Patent Details
  31. Global API Manufacturers
  32. India
  33. Market Competitors
  34. Emerging Therapies
  35. SWOT Analysis
  36. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/4bdgql/cinryze_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs